Stapokibart, Granted Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-to-severe Atopic Dermatitis in Adults Published on 08/07/2025 at 18:05 | prnewswire.co.uk Keymed China California View original content:https://www.prnewswire.co.uk/news-releases/stapokibart-was-granted-marketing-approval-from-national-medical-products-administration-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-in-adults-302246844.html en | boerse | 67969237 |
